XML 13 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements Of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenue
Operating Expenses:        
Sales and Marketing 18,220 19,936 100,645 130,879
General and Administrative 65,865 87,790 134,107 126,557
Research and Development 40,764 234,837 70,532 346,256
Total Operating Expenses 124,849 342,563 305,284 603,692
Loss from Operations (124,849) (342,563) (305,284) (603,692)
Other Expense (Income)        
Interest Expense, Net (211,675) (564,398) (497,234) (997,328)
Bank and Financing Fees 4,183 3,848 4,319 8,332
Other Income 1,920
Total Other Expense (215,858) (568,246) (501,553) (1,003,740)
Loss Before Income Tax (340,707) (910,809) (806,837) (1,607,432)
Income Tax
Net Loss (340,707) (910,809) (806,837) (1,607,432)
Less: Preferred Stock Dividends 2,500 2,500 5,000 5,000
Net Loss Available to Common Stockholders $ (343,207) $ (913,309) $ (811,837) $ (1,612,432)
Net Loss per Common Share:        
Basic $ (0.01) $ (0.01) $ (0.02)
Diluted $ (0.01) $ (0.01) $ (0.02)
Weighted Average Number of Common Shares Outstanding - Basic 78,105,395 70,769,030 76,882,226 70,129,937
Weighted Average Number of Common Shares Outstanding - Diluted 78,105,395 70,769,030 76,882,226 70,129,937